Opinion: What Novo Nordisk has learnt from the Cities Changing Diabetes partnership
Camilla Sylvest, (Nov 2, 2017)
Novo Nordisk’s Camilla Sylvest explains how the Danish pharmaceuticals company has been collaborating with cities since 2014 to combat the global rise in type 2 diabetes. The coalition of nine cities aims to prevent 100 million new cases by 2045 by working together to tackle obesity